Is Pengana Capital Group Partnering With Antipodes to Boost Global Investment Returns?
Source: Kapitales Research
Highlights
• Pengana Capital Group Limited (ASX: PCG) shares rose nearly 4.17% at the time of writing, trading at AU$0.750 after gaining AU$0.030 during the session.
• The company has entered an agreement with Antipodes Partners to assist with the management of the Pengana International Equities Limited (PIA) portfolio.
• The collaboration is expected to strengthen investment management capability and support long-term shareholder outcomes.
Pengana Capital Group Limited (ASX: PCG) recorded a share price increase of nearly 4.17% at the time of writing, trading at AU$0.750 following a AU$0.030 gain during the session. The movement comes after the company announced a strategic agreement aimed at enhancing its investment management capabilities.
Strategic Partnership to Strengthen Portfolio Management
Pengana confirmed that it has entered into an agreement with Antipodes Partners Limited to support the management of the Pengana International Equities Limited (PIA) investment portfolio. The partnership will see the portfolio managed in alignment with the Antipodes Global SMID Strategy, which focuses on global small- and mid-capitalisation companies listed across international exchanges.
Antipodes is a well-known Australian-based global equities investment manager with an established track record in delivering long-term investment performance. The firm recently received recognition at the 2026 Morningstar Awards for Investing Excellence in Australia, highlighting its strong reputation within the investment management industry.
Investment Strategy Alignment
Under the new arrangement, the portfolio will continue investing in a diversified selection of ethically screened global equities while maintaining the existing investment mandate and ASX listing structure of PIA. The strategy emphasises deep fundamental research, disciplined portfolio construction, and risk-adjusted return generation across global markets.
Management believes that incorporating Antipodes’ global equities expertise will enhance the investment management proposition and better align with the long-term interests of shareholders.
Note:
The data presented above is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Is Pengana Capital Group Partnering With Antipodes to Boost Global Investment Returns?
Highlights
• Pengana Capital Group Limited (ASX: PCG) shares rose nearly 4.17% at the time of writing, trading at AU$0.750 after gaining AU$0.030 during the session.
• The company has entered an agreement with Antipodes Partners to assist with the management of the Pengana International Equities Limited (PIA) portfolio.
• The collaboration is expected to strengthen investment management capability and support long-term shareholder outcomes.
Pengana Capital Group Limited (ASX: PCG) recorded a share price increase of nearly 4.17% at the time of writing, trading at AU$0.750 following a AU$0.030 gain during the session. The movement comes after the company announced a strategic agreement aimed at enhancing its investment management capabilities.
Strategic Partnership to Strengthen Portfolio Management
Pengana confirmed that it has entered into an agreement with Antipodes Partners Limited to support the management of the Pengana International Equities Limited (PIA) investment portfolio. The partnership will see the portfolio managed in alignment with the Antipodes Global SMID Strategy, which focuses on global small- and mid-capitalisation companies listed across international exchanges.
Antipodes is a well-known Australian-based global equities investment manager with an established track record in delivering long-term investment performance. The firm recently received recognition at the 2026 Morningstar Awards for Investing Excellence in Australia, highlighting its strong reputation within the investment management industry.
Investment Strategy Alignment
Under the new arrangement, the portfolio will continue investing in a diversified selection of ethically screened global equities while maintaining the existing investment mandate and ASX listing structure of PIA. The strategy emphasises deep fundamental research, disciplined portfolio construction, and risk-adjusted return generation across global markets.
Management believes that incorporating Antipodes’ global equities expertise will enhance the investment management proposition and better align with the long-term interests of shareholders.
Note:
The data presented above is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au